Related Experiment Video
Updated: Nov 8, 2025

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Chronic headaches and middle meningeal artery embolization
Joshua S Catapano1, Katherine Karahalios1, Visish M Srinivasan1
1Department of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, USA.
Middle meningeal artery embolization improved chronic headaches in most patients with chronic subdural hematoma. This minimally invasive procedure offers a potential new treatment for persistent headaches.
Area of Science:
- Neurology
- Interventional Radiology
- Neurosurgery
Background:
- The middle meningeal artery (MMA) is linked to chronic headaches.
- No prior studies have investigated MMA embolization for headache treatment.
Purpose of the Study:
- To evaluate the effectiveness of MMA embolization in resolving or improving chronic headaches in patients with chronic subdural hematoma (cSDH).
Main Methods:
- Retrospective analysis of patients treated for cSDH with MMA embolization (2018-2020).
- Follow-up calls assessed chronic headache history (≥2 years) and symptoms (≥2 days/month).
- Headache Impact Test-6 (HIT-6) scores were recorded before and after embolization.
Main Results:
- Of 46 analyzed patients, 9 (20%) had pre-existing chronic headaches.
- Eight of nine patients reported headache improvement, with seven experiencing complete resolution post-embolization.
- Mean HIT-6 scores significantly decreased from 64.0 to 40.0 (p<0.001) after MMA embolization.
Conclusions:
- MMA embolization appears effective in improving chronic headaches in patients with cSDH.
- Further prospective research is recommended to confirm MMA embolization's utility for treating chronic headaches.
More Related Videos
07:43Utilizing a Cranial Window to Visualize the Middle Cerebral Artery During Endothelin-1 Induced Middle Cerebral Artery Occlusion
Published on: February 22, 2013
14:58Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
Published on: October 20, 2017